Daniel  Karlin net worth and biography

Daniel Karlin Biography and Net Worth

Dan joined MindMed as Chief Medical Officer in February 2021 following MindMed’s acquisition of HealthMode, the company he co-founded and led as CEO.

Prior to HealthMode, he built and led clinical, informatics, and regulatory strategy for Pfizer’s Digital Medicine and Innovation Research Lab. He also served as Global Clinical Lead for psychiatry clinical compounds at Pfizer. He previously served as founder and Chief Medical Officer at Column Health, a leading technology-enabled psychiatry and addiction practice. He is a strategic advisor to several pharmaceutical, biotech, and health technology companies. He is also a founding Advisor to the Digital Biomarkers Journal, co-founder and Board Chair of the Digital Medicine Society (DiMe), and was on the committee for Leadership for Digital Drug Development Tools at Critical Path Alzheimer’s Disease, MJFF, and Mental Health IT at the APA.

Dan is Board Certified in Psychiatry, Addiction Medicine, and Clinical Informatics. He is a Fellow of the APA and the American Society of Addiction Medicine and an Assistant Professor of Psychiatry at Tufts University School of Medicine. He graduated with degrees in Neuroscience and Behavior (BA), and Clinical Informatics (MA), Columbia University; Medicine (MD), University of Colorado School of Medicine.

What is Daniel Karlin's net worth?

The estimated net worth of Daniel Karlin is at least $5.35 million as of September 25th, 2025. Dr. Karlin owns 430,625 shares of Mind Medicine (MindMed) stock worth more than $5,352,669 as of December 5th. This net worth approximation does not reflect any other investments that Dr. Karlin may own. Additionally, Dr. Karlin receives an annual salary of $658,520.00 as Insider at Mind Medicine (MindMed). Learn More about Daniel Karlin's net worth.

How old is Daniel Karlin?

Dr. Karlin is currently 44 years old. There are 5 older executives and no younger executives at Mind Medicine (MindMed). The oldest executive at Mind Medicine (MindMed) is Dr. Miriam Halperin Wernli B.A., M.A., M.B.A., MBA, Ph.D., Executive President, who is 71 years old. Learn More on Daniel Karlin's age.

What is Daniel Karlin's salary?

As the Insider of Mind Medicine (MindMed) Inc., Dr. Karlin earns $658,520.00 per year. The highest earning executive at Mind Medicine (MindMed) is Mr. Robert Barrow, CEO & Director, who commands a salary of $931,130.00 per year. Learn More on Daniel Karlin's salary.

How do I contact Daniel Karlin?

The corporate mailing address for Dr. Karlin and other Mind Medicine (MindMed) executives is , , . Mind Medicine (MindMed) can also be reached via phone at 650-208-2454 and via email at [email protected]. Learn More on Daniel Karlin's contact information.

Has Daniel Karlin been buying or selling shares of Mind Medicine (MindMed)?

Daniel Karlin has not been actively trading shares of Mind Medicine (MindMed) over the course of the past ninety days. Most recently, Daniel Karlin sold 7,704 shares of the business's stock in a transaction on Thursday, September 25th. The shares were sold at an average price of $9.77, for a transaction totalling $75,268.08. Following the completion of the sale, the insider now directly owns 430,625 shares of the company's stock, valued at $4,207,206.25. Learn More on Daniel Karlin's trading history.

Who are Mind Medicine (MindMed)'s active insiders?

Mind Medicine (MindMed)'s insider roster includes Robert Barrow (Chief Executive Officer and Board Director), Schond Greenway (CFO), David Gryska (Director), Dan Karlin (Insider), Daniel Karlin (Insider), Carrie Liao (CAO), and Mark Sullivan (Insider). Learn More on Mind Medicine (MindMed)'s active insiders.

Are insiders buying or selling shares of Mind Medicine (MindMed)?

During the last twelve months, insiders at the sold shares 12 times. They sold a total of 149,022 shares worth more than $1,162,173.63. The most recent insider tranaction occured on September, 25th when insider Mark Sullivan sold 11,278 shares worth more than $110,186.06. Insiders at Mind Medicine (MindMed) own 2.5% of the company. Learn More about insider trades at Mind Medicine (MindMed).

Information on this page was last updated on 9/25/2025.

Daniel Karlin Insider Trading History at Mind Medicine (MindMed)

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
9/25/2025Sell7,704$9.77$75,268.08430,625View SEC Filing Icon  
6/25/2025Sell7,848$6.80$53,366.40438,329View SEC Filing Icon  
3/25/2025Sell6,836$6.74$46,074.64446,177View SEC Filing Icon  
See Full Table

Daniel Karlin Buying and Selling Activity at Mind Medicine (MindMed)

This chart shows Daniel Karlin's buying and selling at Mind Medicine (MindMed) by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Mind Medicine (MindMed) Company Overview

Mind Medicine (MindMed) logo
Mind Medicine (MindMed) Inc., a clinical stage biopharmaceutical company, develops novel products to treat brain health disorders. The company's lead product candidates include MM-120, which is in phase 2 for the treatment of generalized anxiety disorder and attention deficit hyperactivity disorder; and MM-402, a R-enantiomer of 3,4-methylenedioxymethamphetamine, which is in phase I clinical trials for the treatment of core symptoms of autism spectrum disorder. Mind Medicine (MindMed) Inc. is headquartered in New York, New York.
Read More

Today's Range

Now: $12.43
Low: $11.80
High: $12.55

50 Day Range

MA: $12.16
Low: $10.67
High: $14.20

2 Week Range

Now: $12.43
Low: $4.70
High: $14.43

Volume

1,199,690 shs

Average Volume

1,427,440 shs

Market Capitalization

$1.22 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.57